IMPLANET (ALIMP.PA) Stock Fundamental Analysis

EPA:ALIMP • FR0013470168

0.204 EUR
-0.01 (-3.32%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

0

ALIMP gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 67 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ALIMP have multiple concerns. ALIMP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ALIMP had negative earnings in the past year.
  • ALIMP had a negative operating cash flow in the past year.
  • In the past 5 years ALIMP always reported negative net income.
  • In the past 5 years ALIMP always reported negative operating cash flow.
ALIMP.PA Yearly Net Income VS EBIT VS OCF VS FCFALIMP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

  • ALIMP's Return On Assets of -29.08% is on the low side compared to the rest of the industry. ALIMP is outperformed by 80.60% of its industry peers.
Industry RankSector Rank
ROA -29.08%
ROE N/A
ROIC N/A
ROA(3y)-38.85%
ROA(5y)-36.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALIMP.PA Yearly ROA, ROE, ROICALIMP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

  • ALIMP has a Gross Margin of 52.11%. This is in the lower half of the industry: ALIMP underperforms 61.19% of its industry peers.
  • ALIMP's Gross Margin has been stable in the last couple of years.
  • ALIMP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.33%
GM growth 5Y-1.07%
ALIMP.PA Yearly Profit, Operating, Gross MarginsALIMP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • ALIMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALIMP has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ALIMP has more shares outstanding
  • Compared to 1 year ago, ALIMP has an improved debt to assets ratio.
ALIMP.PA Yearly Shares OutstandingALIMP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALIMP.PA Yearly Total Debt VS Total AssetsALIMP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of -0.03, we must say that ALIMP is in the distress zone and has some risk of bankruptcy.
  • ALIMP has a worse Altman-Z score (-0.03) than 74.63% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.03
ROIC/WACCN/A
WACC7.1%
ALIMP.PA Yearly LT Debt VS Equity VS FCFALIMP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

  • A Current Ratio of 0.72 indicates that ALIMP may have some problems paying its short term obligations.
  • The Current ratio of ALIMP (0.72) is worse than 89.55% of its industry peers.
  • ALIMP has a Quick Ratio of 0.72. This is a bad value and indicates that ALIMP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.25, ALIMP is doing worse than 91.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.25
ALIMP.PA Yearly Current Assets VS Current LiabilitesALIMP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • ALIMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.95%, which is quite impressive.
  • The Revenue has grown by 52.11% in the past year. This is a very strong growth!
  • Measured over the past years, ALIMP shows a small growth in Revenue. The Revenue has been growing by 4.89% on average per year.
EPS 1Y (TTM)71.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.45%
Revenue 1Y (TTM)52.11%
Revenue growth 3Y15.28%
Revenue growth 5Y4.89%
Sales Q2Q%41.1%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALIMP.PA Yearly Revenue VS EstimatesALIMP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALIMP.PA Yearly EPS VS EstimatesALIMP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 -5 -10 -15 -20 -25

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • ALIMP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALIMP.PA Price Earnings VS Forward Price EarningsALIMP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALIMP.PA Per share dataALIMP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALIMP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IMPLANET

EPA:ALIMP (2/20/2026, 7:00:00 PM)

0.204

-0.01 (-3.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.34M
Revenue(TTM)11.10M
Net Income(TTM)-4.81M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.64
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.08
BVpS-0.01
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -29.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.11%
FCFM N/A
ROA(3y)-38.85%
ROA(5y)-36.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.33%
GM growth 5Y-1.07%
F-Score4
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.97%
Cap/Sales 8.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.25
Altman-Z -0.03
F-Score4
WACC7.1%
ROIC/WACCN/A
Cap/Depr(3y)21.16%
Cap/Depr(5y)17.19%
Cap/Sales(3y)3.98%
Cap/Sales(5y)3.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)52.11%
Revenue growth 3Y15.28%
Revenue growth 5Y4.89%
Sales Q2Q%41.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.58%
OCF growth 3YN/A
OCF growth 5YN/A

IMPLANET / ALIMP.PA FAQ

What is the ChartMill fundamental rating of IMPLANET (ALIMP.PA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to ALIMP.PA.


What is the valuation status for ALIMP stock?

ChartMill assigns a valuation rating of 0 / 10 to IMPLANET (ALIMP.PA). This can be considered as Overvalued.


What is the profitability of ALIMP stock?

IMPLANET (ALIMP.PA) has a profitability rating of 0 / 10.


What is the financial health of IMPLANET (ALIMP.PA) stock?

The financial health rating of IMPLANET (ALIMP.PA) is 0 / 10.